The Institute for International Research will be holding its 8th annual “Generic Drugs Summit” at the Fairmont Hotel in Washington, D.C., September 17-19. According to IIR, this is “the leading independent forum for addressing business and legal concerns impacting the Generics marketplace.”
The conference features three pre-event symposia and workshops on September 17:
- Full day: Generic Biologics: Understanding the Scientific, Legal, Regulatory, Economic and Marketing Implications
- Morning: Strategies for Filing Successful Paragraph IV Certifications
- Afternoon: Understanding How to Submit Quality ANDAs Based on ObR to Reduce Approval Time
The agenda highlights for the main program, September 18-19, are impressive:
- Q&A with Congressman Henry A. Waxman on Hatch-Waxman reform
- Update and Q&A with Senator Debbie Stabenow on hurdles that slow generics from coming to market
- Update on legislative developments
- Current antitrust actions affecting the generics industry
- An executive roundtable
- A view from Wall Street
- A debate on authorized generics
Additionally, each afternoon will split into two separate tracks: one covering intellectual property and legal issues, the other covering business trends and strategy.
For further information and to register, please visit the conference website.
Orange Book Blog is a media partner of this conference.
Orange Book Blog 
Leave a comment